Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when DFNS files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Related Party (new) — The CEO exchanged over $2M of debt he held into equity and received preferential warrant repricing terms not available to other holders, both approved by the Board on which he serves.
T3 Defense CEO converts $2.1M debt into 4.2M shares, gets warrant repricing in board-approved deal
Filed April 28, 2026 · Period ending April 27, 2026 · ~1 min read
Key Changes
-
high
CEO Menachem Shalom converted $2,138,962 of debt (principal plus interest) into 4,174,399 restricted common shares at $0.5124/share, matching the Nasdaq bid price. This eliminates company debt but dilutes existing shareholders by approximately 4.2 million shares.
Item 1.01 verify on EDGAR → -
high
Board reduced CEO's warrant exercise price 66% from $1.50 to $0.5124/share, making his 7,175,662 warrants immediately in-the-money and representing potential additional dilution of 7.2 million shares if exercised.
Item 8.01 verify on EDGAR → -
medium
The converted notes were originally issued to Star 26 Capital in September 2025, then assigned to the CEO through a call option he exercised against Esousa Group Holdings in January 2026.
Item 1.01 verify on EDGAR → -
medium
The 4.2 million shares issued to the CEO are restricted and cannot be sold without SEC registration or an exemption, limiting near-term selling pressure but also signaling illiquidity.
Item 1.01 verify on EDGAR → -
low
Shares were issued in a private placement under Section 4(a)(2) and Rule 506 of Regulation D exemptions, without SEC registration, and carry restrictive legends.
Item 3.02 verify on EDGAR →
Summary
T3 Defense executed a debt-for-equity swap with CEO Menachem Shalom that eliminates $2.1 million in company obligations but significantly dilutes existing shareholders. On April 27, 2026, the Board approved converting Shalom's notes into 4.2 million restricted shares at $0.5124 per share and simultaneously reduced his warrant exercise price by two-thirds, from $1.50 to $0.5124.
The warrant repricing makes an additional 7.2 million shares potentially issuable at the lower price, representing substantial dilution if exercised. Retail investors should note this is a related-party transaction between the company and its CEO, who also sits on the Board that approved the terms.
While the conversion price matched the Nasdaq bid price, the warrant repricing was discretionary and creates immediate value for the CEO at existing shareholders' expense. The converted shares are restricted and cannot be freely traded without registration. Watch for: (1) whether the CEO exercises the repriced warrants in coming quarters, which would trigger another 7.2 million shares of dilution, and (2) any registration statement filing that would allow the CEO to sell his newly acquired shares into the market.
Section-by-Section Diff
Event · Item 3.02 — Unregistered Sales of Equity Securities
T3 Defense issued unregistered equity securities (Exchange Shares) in a private placement under Securities Act exemptions.
Added in current filing · verify on EDGAR →
The information set forth in Items 1.01 and 8.01 of this Current Report on Form 8-K regarding the issuance of the Exchange Shares is incorporated by reference into this Item 3.02. The shares were issued in reliance upon the exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), provided by Section 4(a) (2) of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder. The Exchange Shares bear restrictive legends as required under the Securities Act.
T3 Defense issued Exchange Shares in a private placement without SEC registration, using exemptions under Section 4(a)(2) and Rule 506 of Regulation D. These shares carry transfer restrictions. The specific details of the issuance (number of shares, recipients, consideration) are referenced in Items 1.01 and 8.01 of this same 8-K filing but are not included in the provided excerpt.
Event · Item 8.01 — Other Events
Item 8.01 — Other Events filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
In connection with the consummation of the transactions contemplated by the Star Purchase Agreement on January 12, 2026, the Company issued to Star 26 a warrant to purchase a total of 12,017,648 shares of Common Stock at an exercise price of $1.50 per share (the “Star Warrant”), which was then distributed to the equity holders of Star 26 on a pro rata basis. Mr. Shalom’s share is a warrant to purchase 7,175,662 shares of Common Stock.
The filing provides context that the CEO's warrant originated from a January 2026 Star Purchase Agreement where Star 26 received warrants for 12 million shares at $1.50, which were distributed pro rata to Star 26's equity holders including the CEO. The CEO received approximately 60% of the total warrant package.
Event · Item 9.01 — Financial Statements and Exhibits
T3 Defense entered a Note Exchange Agreement with CEO Menachem Shalom on April 27, 2026.
Added in current filing · verify on EDGAR →
Note Exchange Agreement, dated as of April 27, 2026, between T3 Defense Inc. and Menachem Shalom
T3 Defense Inc. executed a Note Exchange Agreement with Menachem Shalom, who is the company's Chief Executive Officer as indicated by his signature on the filing. This is a related party transaction between the company and its CEO. The specific terms, amounts, and nature of the notes being exchanged are not disclosed in this 8-K filing itself but would be detailed in the attached Exhibit 10.53.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify